Aritajati, T.; Chayakul, C.; Tongyoo, S. Terlipressin for refractory septic shock: a study protocol of a single center, placebo-controlled double-blind phase III RCT (The TERESEP study). Clin Crit Care 2022, 30, 2022:e0003.